Aptevo Therapeutics (APVO) Selling, General & Administrative (2015 - 2026)
Aptevo Therapeutics' Selling, General & Administrative was $2.75 million in Q2 2026, down 5.2% from $2.9 million a year earlier and down 5.7% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Selling, General & Administrative (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aptevo Therapeutics' Selling, General & Administrative was $11.69 million through Jun 30, 2026, up 12.8% year-over-year; for FY2025, it was $11.77 million, up 15.1% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $10.22 million in FY2024 (-13.1%), $11.77 million in FY2023 (-15.2%), $13.87 million in FY2022 (-5.6%) and $14.7 million in FY2021 (+5.4%).
- Quarterly Selling, General & Administrative has moved between $2.11 million (Q3 2024) and $3.86 million (Q1 2022) over five years.
- Compared with a year earlier, Selling, General & Administrative was higher in three of the last eight quarters, with growth averaging 5.3%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2025 (growth of 69.0%); the worst was Q2 2023 (a decline of 26.5%).
- Per Business Quant data, APVO's Selling, General & Administrative in the three quarters before Q2 2026 was $2.91 million (Q1 2026), $2.46 million (Q4 2025) and $3.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Aptevo Therapeutics | 2.50 Mn | -64.50 Mn | - | 2.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.75 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | 2.46 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 2.67 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 3.59 Mn |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | 3.31 Mn |
| Jun 30, 2022 | 3.70 Mn |
| Mar 31, 2022 | 3.86 Mn |
| Dec 31, 2021 | 3.16 Mn |
| Sep 30, 2021 | 3.48 Mn |
API Access
Aptevo Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();